뇌파계 시스템 시장 - 제품, 유형, 용도 및 최종 용도별 - 세계 예측(2024-2032년)

Electroencephalograph Systems Market is poised to expand at 6.4% CAGR between 2024 and 2032 driven by the rising prevalence of neurological disorders and the continuous technological advancements. With an increasing number of individuals affected by conditions, such as epilepsy, Alzheimer's, and Parkinson's diseases, there is a heightened demand for accurate diagnostic tools like electroencephalograph (EEG) systems. Technological innovations, such as wireless connectivity, portable devices, and advanced signal processing algorithms help enhance the efficiency and precision of EEG systems, making them indispensable in the diagnosis and monitoring of neurological conditions.

In February 2024, Neurotechnology upgraded its BrainAccess kits to provide a complete dry-contact electroencephalography solution comprising headwear, electrodes, an electroencephalograph, and software for EEG data collection and visualization, along with general infrastructure for setting up EEG experiments. This rising development of cutting-edge technologies and the product surging acceptance will add to the market growth.

The EEG systems industry is segmented into product, type, application, end-use, and region.

Based on product, the market size from the multi-channel segment is projected to accrue 6.6% CAGR between 2024 and 2032. Multi-channel EEG systems offer enhanced capabilities in monitoring brain activity with higher precision and detail for catering to diverse clinical and research needs. These systems enable simultaneous recording from multiple brain regions for providing comprehensive insights into neurological disorders, sleep patterns, and cognitive functions. The rising prevalence of neurological diseases, coupled with increasing research activities in neuroscience is fueling the demand for advanced multi-channel EEG systems. Additionally, the strong ability to offer real-time data analysis, customizable electrode configurations, and portability for ambulatory monitoring positions will further contribute to the segment growth.

In terms of application, the electroencephalograph systems market from the sleep disorders segment is anticipated to witness 6.3% CAGR through 2032. EEG systems have emerged as essential solutions for diagnosing and monitoring sleep disorders, such as insomnia, sleep apnea, and parasomnias. They also provide invaluable insights into sleep patterns, brain wave activities, and abnormalities during different sleep stages. With the rising global prevalence of sleep disorders due to lifestyle changes and aging populations, the demand for advanced EEG technologies is likely to significantly surge.

Given the regional landscape, the Asia Pacific electroencephalograph systems industry is set to exhibit robust growth between 2024 and 2032 fueled by the increasing healthcare expenditure, rising awareness about neurological disorders, and expanding R&D activities. China, India, Japan, and South Korea are witnessing a surge in demand for EEG systems due to the growing prevalence of neurological conditions, sleep-related disorders, and the need for accurate diagnostic tools. For instance, in August 2023, researchers from the Yong Loo Lin School of Medicine along with the Centre for Sleep and Cognition in collaboration with Oura Health, discovered that Asians report worse sleep than people living in Europe and North America. Strong advancements in healthcare infrastructure, the rising geriatric population, and government initiatives will further augment the regional industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidence of neurological disorders
    • 3.2.1.2 Increased research in neuroscience
    • 3.2.1.3 Technological advancements and product innovations
    • 3.2.1.4 Rising awareness and healthcare infrastructure
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of EEG equipment
    • 3.2.2.2 Challenges in interpretation and standardization
• 3.3 Growth potential analysis
• 3.4 Technological landscape
• 3.5 Porter's analysis
  • 3.5.1 Supplier power
  • 3.5.2 Buyer power
  • 3.5.3 Threat of new entrants
  • 3.5.4 Threat of substitutes
  • 3.5.5 Industry rivalry
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 8-channel EEG
• 5.3 21-channel EEG
• 5.4 25-channel EEG
• 5.5 32-channel EEG
• 5.6 40-channel EEG
• 5.7 Multi-channel EEG

Chapter 6 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Portable device
• 6.3 Standalone device

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Epilepsy
• 7.3 Sleep disorders
• 7.4 Brain tumours and lesions
• 7.5 Stroke
• 7.6 Psychiatric disorders
• 7.7 Brain mapping
• 7.8 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Neurology centers
• 8.4 Diagnostic centers
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Bio-Logic Systems Corporation
• 10.2 BrainScope Company, Inc.
• 10.3 Cadwell Industries, Inc.
• 10.4 Compumedic Neuroscan
• 10.5 Compumedics Limited
• 10.6 EBNeuro S.p.A.
• 10.7 Elekta AB
• 10.8 Interaxon Inc.
• 10.9 Medtronic plc
• 10.10 Natus Medical Incorporated
• 10.11 NeuroWave Systems Inc.